As shown in Figure 4, the odds of vortioxetine treated patients achieving a ≥50% MADRS score reduction from baseline was about 3 times higher than placebo treated patients (Overall OR = 2.87 ...

Now, experts say they may have discovered an unlikely yet accessible treatment for the brain cancer glioblastoma — a little-known antidepressant called vortioxetine. Swiss scientists ...

Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA) to the US FDA for the investigational agent vortioxetine. Vortioxetine (Lu AA21004 ...

And so, researchers from ETH Zurich have zeroed in on an inexpensive antidepressant known as vortioxetine. Also known by the ...

Vortioxetine is an antidepressant used for the treatment of major depressive disorder (MDD) in adults and also investigated as a treatment for generalized anxiety disorder (GAD).

This meta-analysis demonstrated the efficacy of vortioxetine in reducing depression symptoms in adult patients with MDD. Based on both depression rating scales (MADRS and HAM-D24) a significant ...